Syneos Health is a holding company. Through its subsidiaries, Co. is an integrated biopharmaceutical solutions organization. Co.'s segments are: Clinical Solutions, which provides services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, and clinical monitoring; and Commercial Solutions, which provides commercialization services, including deployment solutions, communication solutions (public relations, advertising, and medical communications), and consulting services.
|
Free SYNH Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: SYNH Stock Forecast Based on Zacks ABR data; powered by Xignite |